Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
NASA unveils close-up pictures of the comet popping by from another star - 2Feeling wonder every day improves our health. Here’s how to do it.
- 3Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
- 4Understanding the Rudiments of Tree Administrations
- 5Manual for Conservative SUVs For Seniors
- Scientists sent a menstrual cup to space. This is how it went
- US FDA investigates Takeda's blood disorder drug after pediatric death
- Reality TV star Spencer Pratt, who lost his home in Palisades Fire, is running for mayor of Los Angeles
- Relish the World: Notable Caf\u00e9s You Really want to Attempt
- Scientists dove hundreds of feet into the ocean and found creatures no human has ever seen. Our trash beat us there
- New materials, old physics – the science behind how your winter jacket keeps you warm
- What's inside Mexico's Popocatépetl? Scientists obtain first 3D images of the whole volcano
- An Investigate of 6 Creative Specialty Mixed drinks
- ChatGPT served as "suicide coach" in man's death, lawsuit alleges
